New Rochelle, NY, United States of America

Vern L Schramm

USPTO Granted Patents = 47 (Patent Applications = 9)

CIPO Patents = 11 (Patent Applications = 6)

EPO Patents = 8 (Patent Applications = 5)

Average Co-Inventor Count = 3.1

ph-index = 14

Forward Citations = 489(Granted Patents)

Company Filing History:

40 out of 504

Albert Einstein College of Medicine

patents

17 out of 74

Industrial Research Limited

patents

8 out of 51

Victoria Link Limited

patents

4. 2 out of 3,687

Johns Hopkins University

patents

5. 1 out of 1

Alber Einslein College of Medicine

patent

6. 6 out of 832,843

Other

patents

where one patent can have more than one assignee

Years Active: 1999-2022

Loading Chart...

Areas of Expertise:

DNMT1 Inhibitors

Helicobacter Pylori Treatment

Nucleoside Phosphorylase Inhibitors

Cancer Therapeutics

Saporin-L1 Inhibitors

SIR2 Regulation

Nucleoside Metabolism

Enzyme Detection Methods

Neural Network Applications

Ricin Detection

5'-Methylthioadenosine Inhibitors

Transition State Inhibitors

47 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11518779 - Inhibitors of DNMT1 as anticancer therapeutic agents (2022-12-06),

2. 11186575 - Treatment of helicobacter pylori infections (2021-11-30),

3. 11114184 - DNA methyltransferase 1 transition state structure and uses thereof (2021-09-07),

4. 10294233 - [object Object] (2019-05-21),

5. 10118928 - Treatment of H. pylori infections using MTAN inhibitors (2018-11-06),

6. 9957272 - 3-hydroxypyrrolidine inhibitors of 5'-methylthioadenosine phosphorylase and nucleosidase (2018-05-01),

7. 9522159 - [object Object] (2016-12-20),

8. 9493465 - 3-hydroxypyrrolidine inhibitors of 5'-methylthioadenosine phosphorylase and nucleosidase (2016-11-15),

9. 9290501 - Methods, assays and compounds for treating bacterial infections by inhibiting methylthioinosine phosphorylase (2016-03-22),

10. 8916571 - Methods of treating cancer using inhibitors of 5'-methylthioadenosine phosphorylase (2014-12-23),

11. 8884000 - Saporin-L1 inhibitors and uses thereof (2014-11-11),

12. 8853224 - Acyclic amine inhibitors of nucleoside phosphorylases and hydrolases (2014-10-07),

13. 8835467 - SIR2 regulation (2014-09-16),

14. 8541567 - Transition state structure of 5'-methylthioadenosine/s-adenosylhomocysteine nucleosidases (2013-09-24),

15. 8536319 - Compounds and methods for detecting ricin and uses thereof (2013-09-17),

Title: Vern L Schramm - The Innovative Mind from New Rochelle

Introduction: Vern L Schramm is a distinguished inventor hailing from New Rochelle, NY. His groundbreaking work in the field of biochemistry has revolutionized the way we understand and approach enzyme mechanisms.

Latest Patents: Vern L Schramm holds several patents in the field of biochemistry and enzymology, with his most recent patent focusing on a novel method for enzyme inhibition in metabolic pathways.

Career Highlights: Throughout his illustrious career, Vern L Schramm has been a trailblazer in the field of biochemistry. He has published numerous research papers that have significantly contributed to the scientific community's understanding of enzyme kinetics and mechanisms.

Collaborations: Vern L Schramm has collaborated with leading researchers and institutions worldwide, fostering a culture of innovation and excellence in the field of biochemistry. His collaborative efforts have led to groundbreaking discoveries in enzyme regulation and inhibition.

Conclusion: Vern L Schramm's dedication to advancing the field of biochemistry through his innovative research and patented inventions has solidified his reputation as a pioneering inventor in New Rochelle, NY.

This text is generated by artificial intelligence and may not be accurate.